Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy

Kidney International

Volumn 82, Issue 5, 2012, Pages 548-560

  Cox, Sharon N ^a   Sallustio, Fabio ^a,b   Serino, Grazia ^a,b   Loverre, Antonia ^a   Pesce, Francesco ^a   Gigante, Margherita ^c   Zaza, Gianluigi ^d   Stifanelli, Patrizia F ^e   Ancona, Nicola ^e   Schena, Francesco P ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b Strada Prov le Valenzano Casamassima   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

Author keywords

chemokine; chemokine receptor; IgA nephropathy; lymphocytes; signaling

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FRACTALKINE; MESSENGER RNA; PROTEASOME; PROTEASOME SUBUNIT BETA TYPE 9; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEMATURIA; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 84865275312     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.147     Document Type: Article

References (49)

1. Manno C, Strippoli GF, D'Altri C et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007; 49: 763-775. (Pubitemid 46802935)
2. Schena FP, Coppo R. IgA nephropathies. In: Davison AM, Ritz E, Cameron JS, Winearls C (eds). Oxford Textbook of Clinical Nephrology. 3rd edn Oxford University Press: Oxford, UK, 2005, pp 369-502.
3. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-673.
4. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513. (Pubitemid 40139842)
5. van der Boog PJ, de Fijter JW, Bruijn JA et al. Recurrence of IgA nephropathy after renal transplantation. Ann Med Interne 1999; 150: 137-142. (Pubitemid 29274454)
6. Ponticelli C, Traversi L, Feliciani A et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001; 60: 1948-1954. (Pubitemid 33000001)
7. Cox SN, Sallustio F, Serino G et al. Altered modulation of WNT-betacatenin and PI3K/Akt pathways in IgA nephropathy. Kidney Int 2010; 78: 396-407.
8. Coppo R, Camilla R, Amore A et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol. 2010; 159: 73-81.
9. Coppo R, Camilla R, Alfarano A et al. Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 2009; 75: 536-541.
10. Coppo R, Amore A, Peruzzi L et al. Innate immunity and IgA nephropathy. J Nephrol 2010; 23: 626-632.
11. Sharmin S, Shimizu Y, Hagiwara M et al. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 2004; 17: 504-511. (Pubitemid 39302877)
12. Amore A, Coppo R, Nedrud JG et al. The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus. Clin Immunol 2004; 113: 101-108. (Pubitemid 39468273)
13. Suzuki S, Nakatomi Y, Sato H et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-16.
14. Koyama A, Sharmin S, Sakurai H et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 2004; 66: 121-132. (Pubitemid 38870088)
15. Kennel-de March A, Bene MC, Renoult E et al. Enhanced expression of L-selectin on peripheral blood lymphocytes from patients with IgA nephropathy. Clin Exp Immunol 1999; 115: 542-546. (Pubitemid 29130373)
16. Batra A, Smith AC, Feehally J et al. T-cell homing receptor expression in IgA nephropathy. Nephrol Dial Transplant 2007; 22: 2540-2548. (Pubitemid 47365518)
17. Nishimura M, Umehara H, Nakayama T et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168: 6173-6180. (Pubitemid 34620036)
18. Fraticelli P, Sironi M, Bianchi G et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107: 1173-1181. (Pubitemid 32422914)
19. Furuichi K, Wada T, Iwata Y et al. Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron 2001; 87: 314-320. (Pubitemid 32260831)
20. Ito Y, Kawachi H, Morioka Y et al. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int 2002; 61: 2044-2057. (Pubitemid 34539322)
21. Koziolek MJ, Müller GA, Zapf A et al. Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Nephrol Dial Transplant 2010; 25: 684-698.
22. Segerer S, Hughes E, Hudkins KL et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62: 488-495. (Pubitemid 34779759)
23. Feng L, Chen S, Garcia GE et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 1999; 56: 612-620. (Pubitemid 29353159)
24. Umehara H, Bloom ET, Okazaki T et al. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 34-40. (Pubitemid 38082409)
25. Yoneda O, Imai T, Gouda S et al. NK cell-mediated vascular injury. J Immunol 2000; 164: 4055-4062.
26. Umehara H, Bloom ET, Okazaki T et al. Fractalkine and vascular injury. Trends Immunol 2001; 22: 602-607.
27. Umehara H, Bloom ET, Okazaki T et al. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 34-40. (Pubitemid 38082409)
28. Bennett L, Palucka AK, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723. (Pubitemid 36350866)
29. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615. (Pubitemid 36297546)
30. Cahen R, Francois B, Trolliet P et al. Aetiology of membranous glomerulonephritis: a prospective study of 82 adult patients. Nephrol Dial Transplant 1989; 4: 172-180. (Pubitemid 19113601)
31. Zeng CH, Chen HM, Wang RS et al. Etiology and clinical characteristics of membranous nephropathy in Chinese patients. Am J Kidney Dis 2008; 52: 691-698.
32. Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530. (Pubitemid 27508241)
33. Goda S, Imai T, Yoshie O et al. CX3C-chemokine, fractalkine enhanced adhesion of THP-1 cells to endothelial cells through integrin dependent and independent mechanisms. J Immunol 2000; 164: 4313-4320. (Pubitemid 30215094)
34. Fong AM, Robinson LA, Steeber DA et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188: 1413-1419. (Pubitemid 28489578)
35. Coppo R, Amore A, Peruzzi L et al. Innate immunity and IgA nephropathy. J Nephrol 2010; 23: 626-632.
36. Gharavi AG, Kiryluk K, Choi M et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011; 43: 321-327.
37. Zhou F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol 2009; 28: 239-260.
38. Fang IM, Lin CP, Yang CM et al. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Mol Vis 2005; 11: 443-451.
39. Infante-Duarte C, Weber A, Krätzschmar J et al. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J 2005; 19: 1902-1904. (Pubitemid 41598789)
40. Bjerkeli V, Damås JK, Fevang B et al. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis- possible role in vascular inflammation. Rheumatology 2007; 46: 1422-1427. (Pubitemid 47317087)
41. Ramos MV, Fernández GC, Brando RJ et al. Interleukin-10 and interferongamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology 2010; 129: 600-609.
42. Pachot A, Cazalis MA, Venet F et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol 2008; 180: 6421-6429.
43. Berthoux FC, Hesham M. Clinical course of primary IgA nephropathy. In: Kar Neng Lai (ed). Recent Advances In IgA Nephropathy. World Scientific Publishing: Hong Kong, China, 2009, pp 107-119.
44. Bennett WM, Kincaid-Smith P. Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int 1983; 23: 393-400. (Pubitemid 13148110)
45. Nakatani K, Yoshimoto S, Iwano M et al. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models. Am J Physiol Renal Physiol 2010; 299: 207-216.
46. Manno C, Strippoli GF, D'Altri C et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007; 49: 763-775. (Pubitemid 46802935)
47. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003; 100: 9440-9445. (Pubitemid 37033947)
48. Dell'Oglio MP, Zaza G, Rossini M et al. The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase. J Am Soc Nephrol 2010; 21: 2157-2168.
49. Stifanelli P, Zaza G, Sallustio F et al. 2009##Statistical analysis of differential gene expression levels in small microaray experiments. 6th International Meeting on Computational Intelligence Methods for Bioinformatics and Biostatistics. CIBB, 15-17 October; Genova, Italy.